Layoffs: Zimmer aims to 'keep everybody' following $13.3B Biomet mega-merger (Mass Device)
Your Dashboard for Zimmer-Biomet
Zimmer is poised to become the 2nd-largest player in the orthopedics space by absorbing Biomet, and the company expects to need the entire sales force of both companies.
Zimmer (NYSE:ZMH) president & CEO David Dvorak is looking to avoid layoffs as much as possible following the pending mega-merger with long-time rival Biomet.
Both companies run their own independent distributor networks and Dvorak said he aims to keep both, expecting that the combined portfolio of Zim...
The Orthopedics Industry 
